AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 DEC 10 - (NewsRx.com & NewsRx.net) -- Half of the children born in sub-Saharan Africa each year do not receive routine vaccinations to protect them from debilitating or deadly diseases. An ambitious venture of the Indiana University (UI) School of Medicine and pharmaceutical firm Merck & Co. seeks to reverse that trend in Kenya, where the School has had a strong presence for more than a decade.
The Merck Vaccine Network-Africa has made a $200,000 grant to the School to establish a vaccination services training program for health care workers, creating a training center at Moi University Faculty of Health Sciences in Eldoret, Kenya. The center will develop a sustainable workforce of medical professionals skilled in vaccine management, storage and delivery.
About 10% of Kenyan children die before reaching the age of 5, according to the World Health Organization. Many succumb to diseases preventable through vaccinations.
"There is no single answer to the challenge of increasing access to vaccines in African countries and other developing nations," noted Adel Mahmoud, MD, president of the Merck Vaccine Division. "It will take multiple organizations applying different approaches and solutions. The MVN-A program is a model aimed at supporting vaccination infrastructure in regions where they remain.
Since 1990, the IU School of Medicine and Moi have worked closely to train ...
Source: HighBeam Research, IU Medical School, Merck take shot at vaccinating Kenyan kids.